Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
1.00    0.01 (1.01%)
Bid:
0.982
Ask:
1.00
Spread: 0.018 (1.833%)
Market Cap: £21.26m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Business Update

18 Aug 2025 07:00

RNS Number : 6922V
Quadrise PLC
18 August 2025
 

Certain of the information contained within this announcement is deemed by the Company to constitute inside information as stipulated under The Market Abuse Regulation (EU 596/2014) pursuant to the Market Abuse (Amendment) (EU Exit) Regulations 2018. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

18 August 2025

 

Quadrise plc

("Quadrise", "QED" or the "Company")

 

Business Update

 

 

Quadrise plc (AIM: QED), the technology company focused on the decarbonisation of shipping and heavy industry through deployment of low emission fuels and biofuels, is pleased to provide an update covering progress on its key projects.

Marine

The bilateral agreements between MSC and Cargill, and Quadrise and Cargill (the "Agreements"), remain in near final form, as announced by the Company on 10 June 2025. The Company has not received any adverse feedback from the relevant counterparties, and their internal processes remain ongoing, albeit slower than anticipated. On entry into the Agreements, the trial equipment will be installed and commissioned at the MAC2 site in Antwerp, ahead of the commercial scale trials commencing in due course. However, the commercial scale trials are no longer expected to commence in Q3 2025, as previously expected, as a result of delays in entry of the Agreements.

In the meantime, the Company continues to build the marine business development pipeline aimed at accelerating the commercialisation of bioMSARTM and MSAR®.

Americas

The trials with Sparkle Power SA in Panama have concluded to the satisfaction of the onsite teams and the Company is now awaiting the official results from the engine manufacturer and the client, the conclusions of which will be announced by the Company following receipt. As previously announced, a confirmed successful trial will enable the Company to negotiate Fuel Supply Agreements and facilitate discussions with other regional power producers. The trials are also an important milestone for Quadrise, being the first test for the MSAR® and bioMSAR™ on MAN 4-stroke diesel engines, to confirm the potential to expand product applications.

Morocco

The Company continues to await final approval from the original equipment manufacturer ("OEM"), to progress the planned commercial trial with OCP. All trial equipment is in place pending OEM approval.

US Low Carbon Fuels

Production growth by Valkor in Utah has progressed slower than expected during 2025, and current levels of production have been insufficient to feed the development of mid-stream operations and marketing. Valkor expect this situation to be resolved shortly.

Quadrise and Valkor are currently negotiating a compensation payment to the Company for the deferral of payment of the initial licence fee due to the Company in the amount of USD$350,000 which was originally due in January 2025. A further update will be provided, as appropriate, in due course.

bioMSAR™ and bioMSAR™ Zero development

Quadrise continues to advance several additional joint development and commercial discussions and testing with potential partners and customers to seek to deliver cleaner fuels at a lower cost than alternatives.

Andy Morrison, Chair of Quadrise, commented:

"Whilst much is being done to prepare ourselves for the scale-up of our business, it is disappointing that we have not been able to progress our existing projects as quickly as we had expected. We remain committed to completing these projects, to demonstrating the significant value add to our clients that Quadrise technology can bring, and to being positioned to act quickly as and when further opportunities arise."

 

For further information please contact:

 

Quadrise Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Jason Miles, Chief Technology Officer

 

 

Nominated Adviser

Cavendish Capital Markets Limited

 

 

+44 (0)20 7220 0500

Ben Jeynes

Katy Birkin

George Lawson

 

Joint Brokers

Shore Capital Stockbrokers Limited

 

 

+44 (0)20 7408 4090

Toby Gibbs, Harry Davies-Ball (Corporate Advisory)

Fiona Conroy (Corporate Broking)

 

VSA Capital Limited

Andrew Raca (Corporate Finance)

Andrew Monk (Corporate Broking)

 

 

+44 (0)20 3005 5000

 

Public & Investor Relations

 

 

Tavistock Communications (Financial PR & IR)

Simon Hudson

Nick Elwes

Ruairi Millar

 

+44 (0) 20 7920 3150

 

 BLUE Communications Limited (Marine & Trade PR)

 Rhys Thomas

 Sam Deacon

 

 

 

+44 (0)7595 227750

+44 (0)7527 558846

 

 

 

About Quadrise

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to lower energy costs, pollution and greenhouse gas emissions today for the global power generation, shipping, industrial and oil industries.

Learn more at: www.quadrise.com

 

Follow us on social media:

LinkedIn: @Quadrise Plc

X: @QuadrisePlc

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDKZGMRKRMGKZG
Date   Source Headline
29th Mar 20237:00 amRNSInterim Results
28th Mar 20237:00 amRNSChange of Company Name
22nd Oct 20155:26 pmRNSDelisting of Quintain ordinary shares
15th Oct 20154:30 pmRNSHolding(s) in Company
15th Oct 20154:30 pmRNSHolding(s) in Company
13th Oct 20154:30 pmRNSHolding(s) in Company
13th Oct 20154:30 pmRNSHolding(s) in Company
13th Oct 20154:30 pmRNSHolding(s) in Company
8th Oct 201512:20 pmRNSCompulsory Acqn Procedure
5th Oct 20157:00 amRNSPosting of response circular to increased offer
30th Sep 20155:44 pmRNSStatement re Increased Cash Offer
29th Sep 20154:30 pmRNSHolding(s) in Company
29th Sep 20154:30 pmRNSHolding(s) in Company
29th Sep 20153:15 pmRNSForm 8.5 (EPT/RI)Replacement QUINTAIN ESTATES
28th Sep 20154:31 pmRNSTotal Voting Rights
28th Sep 20154:30 pmRNSDirectors' Shareholding
28th Sep 20154:28 pmRNSForm 8.5 (EPT/RI)Replacement QUINTAIN ESTATES
28th Sep 20153:15 pmRNSForm 8.3 - Quintain Estates and Development Plc
28th Sep 20152:56 pmRNSForm 8.3 - Quintain Estates and Development PLC
28th Sep 20152:40 pmBUSForm 8.3 - Quintain Corp
28th Sep 201511:51 amRNSForm 8.5 (EPT/RI)-Quintain Estates&Development Plc
28th Sep 201511:51 amRNSForm 8.1 (DD) - Quintain Estates and Development
28th Sep 201511:12 amRNSForm 8.5 (EPT/RI)QUINTAIN ESTATES AND DEVELOPMENT
28th Sep 201511:11 amRNSForm 8.5 (EPT/RI)QUINTAIN ESTATES AND DEVELOPMENT
28th Sep 201511:10 amRNSForm 8.5 (EPT/RI)QUINTAIN ESTATES AND DEVELOPMENT
28th Sep 201510:36 amRNSForm 8.3 - Quintain Estates & Development PLC
28th Sep 20157:26 amRNSRevised Offer Document Posted
25th Sep 20156:27 pmRNSForm 8.3 - Quintain Estates and Development Plc
25th Sep 20154:45 pmRNSDelisting and Board changes
25th Sep 20154:30 pmRNSHolding(s) in Company
25th Sep 20154:30 pmRNSHolding(s) in Company
25th Sep 20152:58 pmRNSForm 8.3 - [Quintain Estates & Dev Plc]
25th Sep 20152:53 pmRNSForm 8.5 (EPT/RI)Replacement QUINTAIN ESTATES
25th Sep 20152:48 pmRNSForm 8.5 (EPT/RI)Replacement QUINTAIN ESTATES
25th Sep 20152:47 pmRNSForm 8.3 - Quintain Estates and Development Plc
25th Sep 20152:44 pmBUSFORM 8.5 (EPT/NON-RI) - QUINTAIN ESTATES & DEVELOPMENT PLC
25th Sep 20151:40 pmRNSReplacement: Offer Unconditional In All Respects
25th Sep 201512:53 pmRNSIncreased Cash Offer
25th Sep 201512:30 pmRNSOffer Unconditional In All Respects
25th Sep 201511:52 amRNSForm 8.5 (EPT/RI)-Quintain Estates&Development Plc
25th Sep 201511:34 amBUSForm 8.5 (EPT/NON-RI) - QUINTAIN ESTATES & DEVELOPMENT
25th Sep 201510:54 amRNSForm 8.5 (EPT/RI) Quintain Estates and Development
25th Sep 201510:53 amRNSForm 8.5 (EPT/RI)QUINTAIN ESTATES AND DEVELOPMENT
25th Sep 201510:17 amRNSForm 8.5 (EPT/RI)-Quintain Estates&Development Plc
25th Sep 201510:16 amRNSForm 8.5 (EPT/RI)-Quintain Estates&Development Plc
25th Sep 20157:59 amRNSIncreased Offer
24th Sep 20155:46 pmRNSForm 8.3 - Quintain Estates and Development Plc
24th Sep 20154:47 pmRNSHolding(s) in Company
24th Sep 20154:32 pmRNSHolding(s) in Company
24th Sep 20153:30 pmRNSForm 8.3 - Quintain Estates

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.